NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,189 Cr | ₹856 Cr | ₹621 Cr | ₹413 Cr | ₹551 Cr |
What is the latest Sundry Debtors ratio of NATCO PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹1,189 Cr |
Mar2023 | ₹856 Cr |
Mar2022 | ₹621 Cr |
Mar2021 | ₹413 Cr |
Mar2020 | ₹551 Cr |
How is Sundry Debtors of NATCO PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹1,189 Cr | 38.87 | |
Mar2023 | ₹856 Cr | 37.95 | |
Mar2022 | ₹621 Cr | 50.30 | |
Mar2021 | ₹413 Cr | -25.10 | |
Mar2020 | ₹551 Cr | - |
Compare Sundry Debtors of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,499.0 Cr | -5.5% | 1.5% | -21.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -5.5% |
1.5% |
-21.2% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses